Assay and Drug Development Technologies
ISSN 1540-658x · Mary Ann Liebert, Inc. · United States · active 1950–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Assay and Drug Development Technologies a predatory journal?
Our screening does not flag Assay and Drug Development Technologies. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Assay and Drug Development Technologies indexed in Scopus or Web of Science?
Per our venue index, Assay and Drug Development Technologies appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Assay and Drug Development Technologies's impact?
Papers in Assay and Drug Development Technologies are cited about 2.1 times each within two years of publication, and Scimago places it in Q3, with an h-index of 72. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Assay and Drug Development Technologies open access?
We hold no reliable open-access classification for Assay and Drug Development Technologies. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Progress in Energy and Combustion ScienceQ1 · Elsevier BV
- Nature Machine IntelligenceQ1 · Nature Portfolio
- Progress in Aerospace SciencesQ1 · Elsevier BV
- Nature Reviews Drug DiscoveryQ1 · Nature Portfolio
- Formal Aspects of ComputingQ3 · Springer Science+Business Media
- Applied Mechanics ReviewsQ1 · American Society of Mechanical Engineers